CTRI/2024/07/071199尚未招募Unknown
A cross sectional, non-randomized clinical performance study to collect the data using Vivaray Hb pro and use the device generated hemoglobin value for validation by comparing it with the hemoglobin value generated from the gold standard (calibrated blood cell counter). - NI
Bosch Global Software Technologies Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Male or Female patients with age of greater than eight (8) years
- •2. Range of Hemoglobin 4-18 g/dl.
- •3. Able to give written informed consent, assent or parents’ consent form.
- •4. Finger size: 8 mm to 23 mm (The device is designed to fit fingers in this range) and index finger preferred to capture the signal.
排除标准
- •1. Patients with paronychia, fungal infections of the nail bed, blistering disorders involving the fingers, hyper-keratosis, nail polish, mehendi and callus formation on nail.
研究者
相似试验
进行中（未招募）
不适用
Wound healing properties of a topical wound healing producthealthy volunteersintended indication is the treatment of acute wounds such as abrasions, cuts, scratches, laceration, blistering burns and sunburnsEUCTR2014-001374-34-DEMEDICE Arzneimittel Pütter GmbH & Co. KG
已完成
2 期
Prospective, non-randomized, non-blinded clinical trial of granulocyte colony-stimulating factor for acute spinal cord injuryspinal cord injuryJPRN-UMIN000024521Ministry of Health, Labour and Welfare60
招募中
不适用
An epidemiological, non-interventional study to determine the prevalence of clinical Subtypes of Constipation in INdian patients.CTRI/2015/01/005470Abbott India Limited920
进行中（未招募）
不适用
A prospective, non-randomised, non-controlled, open label, multicentre phase II study: PTK 787/ZK222584 in patients with advanced neuroendocrine tumours - PTK878/ZK 222584 in patients with advanced NETeuroendocrine TumourEUCTR2004-002420-18-GBCHARITE Universitätsmedizin Berlin Campus Virchow-Klinikum35
招募中
1 期
A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybuprocaine 0.4% eye drops anesthesia for clinical practice in pediatric population.male/female outpatients, aged 0-17 years scheduled to undergo ocular exams with a need of ocular surface anesthesia.CTIS2023-504477-21-01Sintetica S.A.74